JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shultz, M. A.
Right arrow Articles by Buckpitt, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shultz, M. A.
Right arrow Articles by Buckpitt, A.

Vol. 296, Issue 2, 510-519, February 2001

Metabolic Capabilities of CYP2F2 with Various Pulmonary Toxicants and Its Relative Abundance in Mouse Lung Subcompartments

Michael A. Shultz1, Dexter Morin, Ai-Min Chang and Alan Buckpitt

Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis

The tissue- and species-selective toxicity of a number of pulmonary toxicants has been attributed to the presence and distribution of activating enzymes with high kcat in target airways of susceptible species. The mouse is especially sensitive to a variety of metabolically activated lung toxicants. Recombinant CYP2F2 (mouse) was recently shown to effectively metabolize the species-selective pulmonary toxicant naphthalene. Here we show that the pulmonary toxicants 1-nitronaphthalene and 2-methylnaphthalene are metabolized readily with high kcat values (17.1 and 67.6 min-1, respectively) to potentially cytotoxic intermediates at biologically relevant Km values (21.5 and 3.7 µM, respectively). Additionally, anthracene and benzo[a]pyrene are both metabolized by CYP2F2 (0.14 ± 0.04 and 0.04 ± 0.00 nmol/nmol/min, respectively), albeit at much lower rates. The levels of total CYP in mouse airways are considerably higher than those in parenchyma and trachea, and this is consistent with much higher rates of naphthalene metabolism in microsomal preparations from airways compared with the other subcompartments. The data suggest that CYP2F2 is a prominent cytochrome P450 in mouse lung that metabolizes a number of pulmonary toxicants. The presence of CYP2F2 may be important in the susceptibility of the mouse to metabolically activated pulmonary toxicants.

1 Present address: Molecular Dynamics, 928 East Arques Ave., Sunnyvale, CA 94086.

0022-3565/01/2962-0510$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Cancer Res.Home page
F. Kassie, L. B. Anderson, R. Scherber, N. Yu, D. Lahti, P. Upadhyaya, and S. S. Hecht
Indole-3-carbinol Inhibits 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Plus Benzo(a)pyrene-Induced Lung Tumorigenesis in A/J Mice and Modulates Carcinogen-Induced Alterations in Protein Levels
Cancer Res., July 1, 2007; 67(13): 6502 - 6511.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
P.-G. Forkert, R. M. Baldwin, B. Millen, L. H. Lash, D. A. Putt, M. A. Shultz, and K. S. Collins
PULMONARY BIOACTIVATION OF TRICHLOROETHYLENE TO CHLORAL HYDRATE: RELATIVE CONTRIBUTIONS OF CYP2E1, CYP2F, AND CYP2B1
Drug Metab. Dispos., October 1, 2005; 33(10): 1429 - 1437.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. M. Baldwin, M. A. Shultz, and A. R. Buckpitt
Bioactivation of the Pulmonary Toxicants Naphthalene and 1-Nitronaphthalene by Rat CYP2F4
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 857 - 865.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
A. C. Simmonds, C. A. Reilly, R. M. Baldwin, B. I. Ghanayem, D. L. Lanza, G. S. Yost, K. S. Collins, and P.-G. Forkert
BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
Drug Metab. Dispos., September 1, 2004; 32(9): 1032 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. Boland, C. Y. Lin, D. Morin, L. Miller, C. Plopper, and A. Buckpitt
Site-Specific Metabolism of Naphthalene and 1-Nitronaphthalene in Dissected Airways of Rhesus Macaques
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 546 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
G. L. Baker, M. A. Shultz, M. V. Fanucchi, D. M. Morin, A. R. Buckpitt, and C. G. Plopper
Assessing Gene Expression in Lung Subcompartments Utilizing In Situ RNA Preservation
Toxicol. Sci., January 1, 2004; 77(1): 135 - 141.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.